Lori A. Ehrlich

1.0k total citations
20 papers, 707 citations indexed

About

Lori A. Ehrlich is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Lori A. Ehrlich has authored 20 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Molecular Biology. Recurrent topics in Lori A. Ehrlich's work include Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Lori A. Ehrlich is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Lori A. Ehrlich collaborates with scholars based in United States, Slovakia and Malaysia. Lori A. Ehrlich's co-authors include G. David Roodman, Sun Jin Choi, Diane F. Jelinek, Natalie S. Callander, Junwon Lee, Ho Yeon Chung, Irene M. Ghobrial, G. David Roodman, Suzanne Lentzsch and Nicola Giuliani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Lori A. Ehrlich

20 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori A. Ehrlich United States 9 465 409 302 84 49 20 707
Lorenz Kleeberg Germany 10 359 0.8× 372 0.9× 392 1.3× 55 0.7× 19 0.4× 16 674
John D. Iuliucci United States 13 212 0.5× 122 0.3× 316 1.0× 95 1.1× 19 0.4× 16 637
Anna Mansour France 8 155 0.3× 154 0.4× 266 0.9× 151 1.8× 68 1.4× 10 485
Sosana Delimpasi Greece 12 364 0.8× 509 1.2× 399 1.3× 22 0.3× 25 0.5× 61 649
Akihito Fujimi Japan 9 275 0.6× 424 1.0× 213 0.7× 152 1.8× 6 0.1× 41 739
Elisabeth Paietta United States 17 114 0.2× 549 1.3× 309 1.0× 108 1.3× 20 0.4× 26 751
J A Katzmann United States 9 153 0.3× 298 0.7× 156 0.5× 72 0.9× 8 0.2× 20 592
Loredana Santo United States 9 326 0.7× 456 1.1× 383 1.3× 83 1.0× 17 0.3× 23 633
John Hewson Australia 13 168 0.4× 285 0.7× 265 0.9× 154 1.8× 5 0.1× 19 638
Chozha Vendan Rathinam United States 8 116 0.2× 328 0.8× 279 0.9× 241 2.9× 17 0.3× 16 646

Countries citing papers authored by Lori A. Ehrlich

Since Specialization
Citations

This map shows the geographic impact of Lori A. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Ehrlich more than expected).

Fields of papers citing papers by Lori A. Ehrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori A. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Ehrlich. The network helps show where Lori A. Ehrlich may publish in the future.

Co-authorship network of co-authors of Lori A. Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Lori A. Ehrlich. A scholar is included among the top collaborators of Lori A. Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori A. Ehrlich. Lori A. Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Edwin C.Y., Alexei Ionan, Shwu‐Luan Lee, et al.. (2024). FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation. Clinical Cancer Research. 30(19). 4266–4271. 2 indexed citations
2.
Ehrlich, Lori A., et al.. (2024). An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia. Cancers. 16(21). 3615–3615. 4 indexed citations
3.
Howlader, Nadia, Elad Sharon, Lori A. Ehrlich, et al.. (2023). The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990–2018. Cancer Epidemiology Biomarkers & Prevention. 32(6). 744–747. 5 indexed citations
4.
Sekeres, Mikkael A., Nina Kim, Amy E. DeZern, et al.. (2023). Considerations for Drug Development in Myelodysplastic Syndromes. Clinical Cancer Research. 29(14). 2573–2579. 3 indexed citations
5.
Sweet, Kendra, Jörge E. Cortes, Jane F. Apperley, et al.. (2022). Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia. Clinical Cancer Research. 29(12). 2179–2183. 1 indexed citations
6.
7.
Gormley, Nicole, Vishal Bhatnagar, Lori A. Ehrlich, et al.. (2017). FDA analysis of MRD data in hematologic malignancy applications.. Journal of Clinical Oncology. 35(15_suppl). 2541–2541. 5 indexed citations
8.
Ehrlich, Lori A., Virginia E. Kwitkowski, Gregory H. Reaman, et al.. (2017). U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia. Pediatric Blood & Cancer. 64(12). 13 indexed citations
9.
Jarow, Jonathan P., Sandra J. Casak, Meredith K. Chuk, Lori A. Ehrlich, & Sean Khozin. (2016). The Majority of Expedited Investigational New Drug Safety Reports Are Uninformative. Clinical Cancer Research. 22(9). 2111–2113. 17 indexed citations
10.
Ehrlich, Lori A., Katherine Yang‐Iott, Amy DeMicco, & Craig H. Bassing. (2015). Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia. Cell Cycle. 14(3). 388–398. 3 indexed citations
11.
Ehrlich, Lori A., Katherine Yang‐Iott, & Craig H. Bassing. (2014). Tcrδtranslocations that delete theBcl11bhaploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia. Cell Cycle. 13(19). 3076–3082. 8 indexed citations
12.
Lentzsch, Suzanne, Lori A. Ehrlich, & G. David Roodman. (2007). Pathophysiology of Multiple Myeloma Bone Disease. Hematology/Oncology Clinics of North America. 21(6). 1035–1049. 37 indexed citations
13.
Alsayed, Yazan, Xavier Leleu, Xiaoying Jia, et al.. (2006). Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma. Clinical Cancer Research. 12(22). 6826–6835. 75 indexed citations
14.
Choi, Sun Jin, Noriyoshi Kurihara, Junwon Lee, et al.. (2006). Eosinophil Chemotactic Factor‐L (ECF‐L) Enhances Osteoclast Formation by Increasing ICAM‐1 Expression. Annals of the New York Academy of Sciences. 1068(1). 240–243. 1 indexed citations
15.
Oba, Yasuo, Junwon Lee, Lori A. Ehrlich, et al.. (2005). MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Experimental Hematology. 33(3). 272–278. 119 indexed citations
16.
Ehrlich, Lori A., Ho Yeon Chung, Irene M. Ghobrial, et al.. (2005). IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood. 106(4). 1407–1414. 147 indexed citations
17.
Ehrlich, Lori A. & G. David Roodman. (2005). The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma. Immunological Reviews. 208(1). 252–266. 75 indexed citations
18.
Ehrlich, Lori A., Masahiro Ito, Sun Jin Choi, & G. David Roodman. (2004). IL-3 Inhibits Osteoblast Formation in Multiple Myeloma Via CD45+ Cells.. Blood. 104(11). 2347–2347. 1 indexed citations
19.
Oba, Yasuo, et al.. (2003). Blocking CCR1 or CCR5 inhibits both osteoclast formation and increased α1‐integrin expression induced by MIP‐1α. European Journal Of Haematology. 70(4). 272–272. 2 indexed citations
20.
Lee, Junwon, Lori A. Ehrlich, Diane F. Jelinek, et al.. (2003). IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood. 103(6). 2308–2315. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenz Kleeberg Breakdown of academic impact, for papers by John D. Iuliucci Breakdown of academic impact, for papers by Anna Mansour Breakdown of academic impact, for papers by Sosana Delimpasi Breakdown of academic impact, for papers by Akihito Fujimi Breakdown of academic impact, for papers by Elisabeth Paietta Breakdown of academic impact, for papers by J A Katzmann Breakdown of academic impact, for papers by Loredana Santo Breakdown of academic impact, for papers by John Hewson Breakdown of academic impact, for papers by Chozha Vendan Rathinam
Rankless by CCL
2026